Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice.

نویسندگان

  • A G Zermansky
  • D R Petty
  • D K Raynor
  • N Freemantle
  • A Vail
  • C J Lowe
چکیده

OBJECTIVE To determine whether a pharmacist can effectively review repeat prescriptions through consultations with elderly patients in general practice. DESIGN Randomised controlled trial of clinical medication review by a pharmacist against normal general practice review. SETTING Four general practices. PARTICIPANTS 1188 patients aged 65 or over who were receiving at least one repeat prescription and living in the community. INTERVENTION Patients were invited to a consultation at which the pharmacist reviewed their medical conditions and current treatment. MAIN OUTCOME MEASURES Number of changes to repeat prescriptions over one year, drug costs, and use of healthcare services. RESULTS 590 (97%) patients in the intervention group were reviewed compared with 233 (44%) in the control group. Patients seen by the pharmacist were more likely to have changes made to their repeat prescriptions (mean number of changes per patient 2.2 v 1.9; difference=0.31, 95% confidence interval 0.06 to 0.57; P=0.02). Monthly drug costs rose in both groups over the year, but the rise was less in the intervention group (mean difference 4.72 pound sterling per 28 days, - 7.04 pound sterling to - 2.41 pound sterling); equivalent to 61 pound sterling per patient a year. Intervention patients had a smaller rise in the number of drugs prescribed (0.2 v 0.4; mean difference -0.2, -0.4 to -0.1). There was no evidence that review of treatment by the pharmacist affected practice consultation rates, outpatient consultations, hospital admissions, or death rate. CONCLUSIONS A clinical pharmacist can conduct effective consultations with elderly patients in general practice to review their drugs. Such review results in significant changes in patients' drugs and saves more than the cost of the intervention without affecting the workload of general practitioners.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Repeat prescribing: a role for community pharmacists in controlling and monitoring repeat prescriptions.

BACKGROUND Traditional systems of managing repeat prescribing have been criticised for their lack of clinical and administrative controls. AIM To compare a community pharmacist-managed repeat prescribing system with established methods of managing repeat prescribing. METHOD A randomised controlled intervention study (19 general medical practices, 3074 patients, 62 community pharmacists). Pa...

متن کامل

Pharmacist-led management of chronic pain in primary care: results from a randomised controlled exploratory trial

OBJECTIVES To compare the effectiveness of pharmacist medication review, with or without pharmacist prescribing, with standard care, for patients with chronic pain. DESIGN An exploratory randomised controlled trial. SETTING Six general practices with prescribing pharmacists in Grampian (3) and East Anglia (3). PARTICIPANTS Patients on repeat prescribed pain medication (4815) were screened...

متن کامل

Clinical pharmacist review: a randomised controlled trial.

OBJECTIVES To determine if medication review by a clinical pharmacist of older patients in the ED impacted on admission to hospital and other outcomes. METHODS A stratified, randomised controlled study comparing the intervention to current practice. A tertiary referral ED in New South Wales, Australia. Older people (>70 years) living at home who initially reported taking greater than five med...

متن کامل

Impact of a pharmacist-led medication review on hospital readmission in a pediatric and elderly population: study protocol for a randomized open-label controlled trial

BACKGROUND Early hospital readmission of patients after discharge is a public health problem. One major cause of hospital readmission is dysfunctions in integrated pathways between community and hospital care that can cause adverse drug events. Furthermore, the French ENEIS 2 study showed that 1.3% of hospital stays originated from serious adverse drug events in 2009. Pharmacy-led medication re...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • BMJ

دوره 323 7325  شماره 

صفحات  -

تاریخ انتشار 2001